The Biotechnology industry had the strongest second quarter since at least 1995, with $1.8 billion flowing into 122 deals and captured the second largest investment total behind the Software industry. Even after excluding two large Biotechnology deals, the sector saw a nearly 40 percent jump in investment dollars over the previous quarter. Biotechnology captured 74 percent of total Life Sciences investment during the second quarter of 2014, identical to the same period last year but higher than the 64 percent Life Sciences investments represented in the first quarter of 2014. Two of the top 10 deals in Q2 were investments in Biotechnology companies and together accounted for $320 million.
Investments in Medical Device companies reached $649 million in 73 deals for the quarter, which represented a 23 percent increase in dollars invested but a five percent decrease in the number of deals. On a quarter-over-quarter basis, funding increased 69 percent for Biotechnology and 23 percent for Medical Devices. On a year-over-year basis, Biotechnology and Medical Device investments increased by 25 percent and 23 percent, respectively, in terms of dollars invested.
First-Time and Follow-on Funding
First-time funding for the Life Sciences sector in Q2 2014 decreased by 20 percent to $267 million while the number of deals decreased by 18 percent to 32 deals, when compared to Q2 2013. However, follow-on funding for the Life Sciences sector increased 34 percent to $2.2 million and the number of deals increased 3 percent to 163 deals, during the second quarter of 2014, when compared to the same period of last year.
"Follow-on funding for biotechnology was the highest since at least 1995 as VCs continue to support companies in their portfolio," Vlahos continued. "Despite the dip in companies receiving an investment for the first time, VCs continue to
|SOURCE PwC US|
Copyright©2014 PR Newswire.
All rights reserved